Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-08-04

FDA Approved: RAMELTEON — Supplemental Application (Granules Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved Granules Pharmaceuticals' supplemental application for Ramelteon, adding a granule formulation of ramelteon.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramelteon (ramelteon)

Snippet

SUPPL AP for RAMELTEON (RAMELTEON)